Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.

David Molina-GarcíaJulián Pérez-BetetaAlicia Martínez-GonzálezJuan M SepúlvedaSergi PeraltaMiguel J Gil-GilGaspar ReynesAna HerreroRamón De Las PeñasRaquel LuqueJaume CapelladesCarmen BalañaVíctor M Pérez-García

Published in: PloS one (2016)

Imaging biomarkers related to the irregularity of contrast enhancing areas and the necrotic volume were able to discriminate GBM patients with a substantial survival benefit from BVZ. A prospective study is needed to validate our results.

Keyphrases

end stage renal disease
magnetic resonance
ejection fraction
newly diagnosed
chronic kidney disease
high resolution
prognostic factors
contrast enhanced
peritoneal dialysis
free survival
computed tomography
patient reported
drug induced